Pfau A, Shepherd E, Martin M, Ascolese S, Mason K, Egert-McLean A
Vet Sci. 2023; 10(9).
PMID: 37756100
PMC: 10537598.
DOI: 10.3390/vetsci10090579.
de Carvalho A, Cordeiro M, Rodrigues L, Ortolani D, Spadari R
Sci Rep. 2021; 11(1):9129.
PMID: 33911098
PMC: 8080723.
DOI: 10.1038/s41598-021-88267-8.
Hegde A, Strachan R, Walker J
PLoS One. 2015; 10(2):e0116458.
PMID: 25658948
PMC: 4319755.
DOI: 10.1371/journal.pone.0116458.
Hagena H, Manahan-Vaughan D
Front Integr Neurosci. 2012; 6:23.
PMID: 22654741
PMC: 3358719.
DOI: 10.3389/fnint.2012.00023.
Schneider T, Michel M
Front Pharmacol. 2011; 1:128.
PMID: 21734891
PMC: 3124131.
DOI: 10.3389/fphar.2010.00128.
Local epicardial inotropic drug delivery allows targeted pharmacologic intervention with preservation of myocardial loading conditions.
Lovich M, Wei A, Maslov M, Wu P, Edelman E
J Pharm Sci. 2011; 100(11):4993-5006.
PMID: 21721001
PMC: 4637939.
DOI: 10.1002/jps.22681.
Preclinical evaluation of an 18F-labelled beta1-adrenoceptor selective radioligand based on ICI 89,406.
Law M, Wagner S, Kopka K, Renner C, Pike V, Schober O
Nucl Med Biol. 2010; 37(4):517-26.
PMID: 20447564
PMC: 3013357.
DOI: 10.1016/j.nucmedbio.2010.01.004.
The influence of diabetes on cardiac beta-adrenoceptor subtypes.
Altan V, Arioglu E, Guner S, Ozcelikay A
Heart Fail Rev. 2007; 12(1):58-65.
PMID: 17364227
DOI: 10.1007/s10741-007-9005-6.
Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium.
Varma D, Shen H, Deng X, Peri K, Chemtob S, Mulay S
Br J Pharmacol. 1999; 127(4):895-902.
PMID: 10433496
PMC: 1566092.
DOI: 10.1038/sj.bjp.0702616.
Synthesis and beta-adrenergic activities of R-fluoronaphthyloxypropanolamine.
Adejare A, Sciberras S
Pharm Res. 1997; 14(4):533-6.
PMID: 9144745
DOI: 10.1023/a:1012172121453.
Binding of beta 1-adrenoceptor antagonist [3H]CGP 26505 in rat cerebral cortex and sinus atrial node.
Chiellini G, Giannaccini G, Martini C, Lucacchini A
Neurochem Res. 1996; 21(10):1149-53.
PMID: 8923473
DOI: 10.1007/BF02532388.
Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing.
Abou-Mohamed G, Nagarajan R, Ibrahim T, Caldwell R
Cardiovasc Drugs Ther. 1996; 10(1):39-47.
PMID: 8723169
DOI: 10.1007/BF00051129.
Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy.
Yamada Y, Shibuya F, Hamada J, Sawada Y, Iga T
J Pharmacokinet Biopharm. 1995; 23(2):131-45.
PMID: 8719233
DOI: 10.1007/BF02354268.
Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.
Paetsch P, Greenshaw A
Cell Mol Neurobiol. 1993; 13(3):203-15.
PMID: 8242685
PMC: 11566813.
DOI: 10.1007/BF00733750.
Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.
Law M
Br J Pharmacol. 1993; 109(4):1101-9.
PMID: 8104642
PMC: 2175765.
DOI: 10.1111/j.1476-5381.1993.tb13736.x.
Evidence for a cooperation between adenosine A2 receptors and beta 1-adrenoceptors on cardiac automaticity in the isolated right ventricle of the rat.
Hernandez J, Pinto F, Figueira M, Riberio J
Br J Pharmacol. 1994; 111(4):1316-20.
PMID: 8032618
PMC: 1910119.
DOI: 10.1111/j.1476-5381.1994.tb14888.x.
The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.
Joyce J
Psychopharmacology (Berl). 1993; 112(1 Suppl):S16-34.
PMID: 7831438
DOI: 10.1007/BF02245004.
Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum.
Huff R, Molinoff P
Proc Natl Acad Sci U S A. 1982; 79(23):7561-5.
PMID: 6961433
PMC: 347380.
DOI: 10.1073/pnas.79.23.7561.
Increased brain serotonergic and noradrenergic activity after repeated systemic administration of the beta-2 adrenoceptor agonist salbutamol, a putative antidepressant drug.
Hallberg H, ALMGREN O, Svensson T
Psychopharmacology (Berl). 1981; 73(3):201-4.
PMID: 6787636
DOI: 10.1007/BF00422402.
A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart.
Delhaye M, De Smet J, Taton G, De Neef P, CAMUS J, Fontaine J
Naunyn Schmiedebergs Arch Pharmacol. 1984; 325(2):170-5.
PMID: 6717612
DOI: 10.1007/BF00506197.
